ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SAEID ELMI M.D.

170 GOVERNORS AVENUE HALLMAK HEALTH MEDICAL ASSOCIATES, INC

Medford | Massachusetts | 02155

(781) 979-2424

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 98

$1.66M Total Retail Price of All Prescriptions

Rank: 5 out of 98

641 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

5% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 25,181 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,799 1,637 1 1
FUROSEMIDE 1,089 906 2 4
TRAZODONE HCL 979 853 3 9
LEVOTHYROXINE SODIUM 956 835 4 5
LISINOPRIL 842 728 5 3
MIRTAZAPINE 824 770 6 11
SIMVASTATIN 798 706 7 2
CITALOPRAM HBR 751 658 8 10
METOPROLOL TARTRATE 724 662 9 8
OLANZAPINE 681 574 10 24
RISPERIDONE 669 498 11 27
AMLODIPINE BESYLATE 660 609 12 7
OMEPRAZOLE 659 568 13 6
DIVALPROEX SODIUM 605 443 14 22
DONEPEZIL HCL 559 537 15 12
QUETIAPINE FUMARATE 521 424 16 23
GABAPENTIN 503 379 17 13
NAMENDA 453 432 18 18
METOPROLOL SUCCINATE 428 378 19 16
POTASSIUM CHLORIDE 383 314 20 21
ATENOLOL 381 350 21 14
CLOZAPINE 377 344 22 55
SERTRALINE HCL 319 287 23 19
LANTUS 295 204 24 28
METFORMIN HCL 288 214 25 15
TAMSULOSIN HCL 266 247 26 25
TRAMADOL HCL 260 238 27 26
FLUOXETINE HCL 252 143 28 48
LACTULOSE 243 107 29 62
RANITIDINE HCL 236 202 30 35
ATORVASTATIN CALCIUM 234 197 31 20
LEVETIRACETAM 228 148 32 38
BENZTROPINE MESYLATE 202 139 R 33 89
ADVAIR DISKUS 199 130 34 32
HYDROCHLOROTHIAZIDE 195 185 35 17
LAMOTRIGINE 182 99 36 87
SEROQUEL 176 146 37 52
ALLOPURINOL 173 150 38 43
IPRATROPIUM-ALBUTEROL 169 123 39 45
PRAVASTATIN SODIUM 168 141 40 41
NYSTATIN 164 124 41 56
PANTOPRAZOLE SODIUM 164 142 41 42
GLIPIZIDE 160 138 43 37
LIDODERM 156 152 44 29
ISOSORBIDE MONONITRATE ER 147 141 45 36
NYSTOP 139 136 46 64
CLOPIDOGREL 138 122 47 50
KLOR-CON M20 137 104 48 69
NOVOLOG 132 107 49 54
VENLAFAXINE HCL 130 115 50 116
DIGOXIN 130 130 50 40
PREDNISONE 130 122 50 31
NOVOLIN R 129 88 53 79
ABILIFY 125 74 54 66
FINASTERIDE 124 110 55 49
VALPROIC ACID 115 76 56 140
POLYETHYLENE GLYCOL 3350 108 77 57 33
CIPROFLOXACIN HCL 106 92 58 86
LOSARTAN POTASSIUM 105 96 59 34
ALENDRONATE SODIUM 103 95 60 30
CARVEDILOL 102 102 61 72
CARBIDOPA-LEVODOPA 100 92 62 44
HYDROCODONE-ACETAMINOPHEN 96 93 S3 63 39
HALOPERIDOL 96 16 63 112
SPIRIVA 94 70 65 46
MUPIROCIN 94 81 65 123
VENLAFAXINE HCL ER 93 86 67 65
DIVALPROEX SODIUM ER 92 72 68 84
METOCLOPRAMIDE HCL 92 72 68 102
BUPROPION HCL 90 58 70 96
CEPHALEXIN 90 78 70 92
TERAZOSIN HCL 89 53 72 94
LEVOFLOXACIN 88 75 73 63
SPIRONOLACTONE 86 48 74 71
SANTYL 85 70 75 156
HYDRALAZINE HCL 83 81 76 75
PHENYTOIN SODIUM EXTENDED 83 69 76 101
PROPRANOLOL HCL 77 52 78 105
DOXAZOSIN MESYLATE 77 77 78 98
PAROXETINE HCL 76 53 80 73
BUSPIRONE HCL 76 69 80 135
CLONIDINE HCL 73 43 82 108
NOVOLIN N 72 48 83 85
IBUPROFEN 68 46 84 74
TOPIRAMATE 67 34 85 148
CYMBALTA 66 56 86 47
DILANTIN 64 36 87 132
ROPINIROLE HCL 64 49 87 91
GEMFIBROZIL 63 49 89 125
LATANOPROST 63 63 89 67
ERYTHROMYCIN 63 57 89 107
METHADONE HCL 62 61 S2 92 126
BUMETANIDE 62 61 92 124
FAMOTIDINE 60 57 94 80
FLUTICASONE PROPIONATE 60 26 94 53
OXYCODONE HCL 60 42 S2 94 61
DIOVAN 60 47 94 57
LITHIUM CARBONATE 60 48 94 188
OXYBUTYNIN CHLORIDE 58 37 99 166
GENERLAC 58 37 99 82
PLAVIX 58 54 99 76
BACLOFEN 57 0 102 59
OXCARBAZEPINE 56 37 103 179
TRIAMCINOLONE ACETONIDE 55 54 104 93
KLOR-CON M10 55 53 104 176
LABETALOL HCL 54 45 106 127
NIFEDIPINE ER 54 52 106 68
FLOVENT HFA 52 29 108 135
THERMAZENE 52 51 108 294
GLYBURIDE 51 42 R 110 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.